Pfizer tests new pill version on healthy volunteers
NCT ID NCT07130097
Summary
This study tested whether a new, more concentrated version of an experimental drug tablet works the same way in the body as the current version. It involved 35 healthy adults who each took a single dose of both tablet types after a meal, with the order decided randomly. The goal was to see if the different tablet formulations affect how the drug is absorbed and processed.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pfizer Clinical Research Unit - New Haven
New Haven, Connecticut, 06511, United States
Conditions
Explore the condition pages connected to this study.